Lurker Nancy — SEC Form 4 filings
SEC reporting owner CIK 1450485. 25 Form 4 filings on record with FilingPulse; latest filed 2026-05-22.
Transaction summary — filings shown
Covers all 25 filings on record, filed 2024-01-09 to 2026-05-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 3,173 shares, $25,003 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 6 legs across 4 filings — 49,500 shares, $1,187,003 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 85.
- Largest priced transaction: sale of 29,956 shares @ $24.98 ($748,250) in EyePoint, Inc., filed 2024-01-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| EyePoint, Inc. (EYPT) | Director | 14 | 1 leg · 3,173 sh · $25,003 | 5 legs · 45,000 sh · $1,025,142 | 57 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | Director | 4 | — | 1 leg · 4,500 sh · $161,861 | 3 |
| Alkermes plc. (ALKS) | Director | 7 | — | — | 25 |
Form 4 filings — Lurker Nancy
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-22 | 4 | Alkermes plc. (ALKS) | Option exercise (M): 6,142 · Tax withholding (F): 1,475 @ $36.95 · Grant/award (A): 11,538 (derivative) @ $0 · Grant/award (A): 5,409 (derivative) @ $0 · Option exercise (M): 6,142 (derivative) | EDGAR |
| 2026-05-18 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/award (A): 8,741 @ $0 | EDGAR |
| 2026-05-15 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Sale (S): 4,500 @ $35.97 | EDGAR |
| 2026-04-13 | 4 | Alkermes plc. (ALKS) | Option exercise (M): 3,751 · Tax withholding (F): 901 @ $33.36 · Option exercise (M): 3,751 (derivative) | EDGAR |
| 2026-01-07 | 4 | EyePoint, Inc. (EYPT) | Option exercise (M): 75,133 @ $0 · Option exercise (M): 75,133 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | EyePoint, Inc. (EYPT) | Option exercise (M): 12,666 @ $0 · Grant/award (A): 40,000 (derivative) @ $0 · Option exercise (M): 12,666 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Sale (S): 9,300 @ $15.11 | EDGAR |
| 2025-12-01 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Sale (S): 200 @ $14.95 · Sale (S): 500 @ $14.95 | EDGAR |
| 2025-07-11 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Option exercise (M): 11,111 @ $0 · Option exercise (M): 11,111 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Gift (G): 31,165 (derivative) @ $0 · Gift (G): 31,165 (derivative) @ $0 · Gift (G): 55,000 (derivative) @ $0 · Gift (G): 55,000 (derivative) @ $0 · Gift (G): 103,308 (derivative) @ $0 · Gift (G): 103,308 (derivative) @ $0 · +4 more | EDGAR |
| 2025-06-02 | 4 | Alkermes plc. (ALKS) | Option exercise (M): 8,013 · Tax withholding (F): 1,924 @ $30.61 · Option exercise (M): 8,013 (derivative) | EDGAR |
| 2025-05-23 | 4 | Alkermes plc. (ALKS) | Grant/award (A): 13,474 (derivative) @ $0 · Grant/award (A): 6,142 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/award (A): 9,791 @ $0 | EDGAR |
| 2025-04-14 | 4 | Alkermes plc. (ALKS) | Option exercise (M): 2,323 · Tax withholding (F): 558 @ $27 · Option exercise (M): 3,752 · Tax withholding (F): 901 @ $27 · Option exercise (M): 2,323 (derivative) · Option exercise (M): 3,752 (derivative) | EDGAR |
| 2025-02-11 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Option exercise (M): 20,000 @ $0 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-02-05 | 4 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/award (A): 12,726 @ $0 | EDGAR |
| 2025-01-07 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Option exercise (M): 12,667 @ $0 · Option exercise (M): 75,134 @ $0 · Grant/award (A): 40,000 (derivative) @ $0 · Option exercise (M): 12,667 (derivative) @ $0 · Option exercise (M): 75,134 (derivative) @ $0 | EDGAR |
| 2024-08-20 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Purchase (P): 3,173 @ $7.88 | EDGAR |
| 2024-07-26 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Gift (G): 1,558 (derivative) @ $0 · Gift (G): 1,558 (derivative) @ $0 · Gift (G): 26,713 (derivative) @ $0 · Gift (G): 26,713 (derivative) @ $0 · Gift (G): 30,000 (derivative) @ $0 · Gift (G): 30,000 (derivative) @ $0 · +4 more | EDGAR |
| 2024-07-12 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Option exercise (M): 11,111 @ $0 · Option exercise (M): 11,111 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | Alkermes plc. (ALKS) | Grant/award (A): 8,013 (derivative) @ $0 · Grant/award (A): 17,492 (derivative) @ $0 | EDGAR |
| 2024-04-12 | 4 | Alkermes plc. (ALKS) | Grant/award (A): 2,323 (derivative) @ $0 · Grant/award (A): 4,833 (derivative) @ $0 · Grant/award (A): 11,255 (derivative) @ $0 · Grant/award (A): 22,103 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Option exercise (M): 20,000 @ $0 · Option exercise (M): 17,534 @ $0 · Tax withholding (F): 7,962 @ $28.80 · Tax withholding (F): 6,981 @ $28.80 · Gift (G): 74,681 @ $0 · Gift (G): 74,681 @ $0 · +8 more | EDGAR |
| 2024-01-25 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Sale (S): 5,044 @ $24.97 · Sale (S): 29,956 @ $24.98 · Gift (G): 112,700 (derivative) @ $0 · Gift (G): 112,700 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Option exercise (M): 75,133 @ $0 · Tax withholding (F): 23,043 @ $20.40 · Grant/award (A): 38,000 (derivative) @ $0 · Grant/award (A): 77,000 (derivative) @ $0 · Option exercise (M): 75,133 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1450485 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →